|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.1.3.48
- protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate
|
 |
 |
 |
 |
 |
O-phospho-L-tyrosyl-[protein]
|
+
|
H2O
|
=
|
L-tyrosyl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Cell
97:449-457
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the tandem phosphatase domains of RPTP LAR.
|
|
H.J.Nam,
F.Poy,
N.X.Krueger,
H.Saito,
C.A.Frederick.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Most receptor-like protein tyrosine phosphatases (RPTPs) contain two conserved
phosphatase domains (D1 and D2) in their intracellular region. The
carboxy-terminal D2 domain has little or no catalytic activity. The crystal
structure of the tandem D1 and D2 domains of the human RPTP LAR revealed that
the tertiary structures of the LAR D1 and D2 domains are very similar to each
other, with the exception of conformational differences at two amino acid
positions in the D2 domain. Site-directed mutational changes at these positions
(Leu-1644-to-Tyr and Glu-1779-to-Asp) conferred a robust PTPase activity to the
D2 domain. The catalytic sites of both domains are accessible, in contrast to
the dimeric blocked orientation model previously suggested. The relative
orientation of the LAR D1 and D2 domains, constrained by a short linker, is
stabilized by extensive interdomain interactions, suggesting that this
orientation might be favored in solution.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon Diagrams of Two Views of the LAR D1D2
MoleculeD1 and D2 domains are shown in pink and cyan,
respectively. On the left, the active site of D1 is facing the
viewer and that of D2 is facing upward. On the right, the same
molecule is rotated along the horizontal axis approximately
90°. (The relative positions of the two active sites
approach a 4-fold screw rotation.) Side chains of residues at
the active sites are shown. The loops connecting β1 and β2 of
D2 are shown in magenta to indicate the location for the acidic
19-residue insertion in CD45. The boxed region is the interface
between the D1 and D2 domains; a detailed view of this area is
shown in Figure 5B. The figure was produced using the program
SETOR ( [7]).
|
 |
Figure 3.
Figure 3. Comparisons between the LAR D1 and D2 Domains(A) A
superposition of main-chain atoms of the LAR D1 (pink) and D2
(cyan) domains. Disordered residues 1624–1627 of D2 are shown
in blue. The loop between the two N-terminal helices (α1′ and
α2′) of D2 is marked with an arrow. The side chains of the
active site Cys are shown in yellow.(B) A stereo view of the
superimposed active sites of the D1 and D2 domains. Side chains
of residues involved in catalysis are shown in pink (D1) and
cyan (D2). For emphasis, key residues used for comparison
between D1 and D2 are colored individually.(C) Surface
representation of the active sites of D1 (left) and D2 (right).
Residues involved in catalysis are shown in the color scheme
following that of the side chains in (B).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1999,
97,
449-457)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.M.Flynn,
J.A.Hanson,
T.Alber,
and
H.Yang
(2010).
Dynamic active-site protection by the M. tuberculosis protein tyrosine phosphatase PtpB lid domain.
|
| |
J Am Chem Soc,
132,
4772-4780.
|
 |
|
|
|
|
 |
S.D.Hinton,
M.P.Myers,
V.R.Roggero,
L.A.Allison,
and
N.K.Tonks
(2010).
The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation.
|
| |
Biochem J,
427,
349-357.
|
 |
|
|
|
|
 |
A.E.Hower,
P.J.Beltran,
and
J.L.Bixby
(2009).
Dimerization of tyrosine phosphatase PTPRO decreases its activity and ability to inactivate TrkC.
|
| |
J Neurochem,
110,
1635-1647.
|
 |
|
|
|
|
 |
A.J.Barr,
E.Ugochukwu,
W.H.Lee,
O.N.King,
P.Filippakopoulos,
I.Alfano,
P.Savitsky,
N.A.Burgess-Brown,
S.Müller,
and
S.Knapp
(2009).
Large-scale structural analysis of the classical human protein tyrosine phosphatome.
|
| |
Cell,
136,
352-363.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Woo,
S.K.Kwon,
S.Choi,
S.Kim,
J.R.Lee,
A.W.Dunah,
M.Sheng,
and
E.Kim
(2009).
Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses.
|
| |
Nat Neurosci,
12,
428-437.
|
 |
|
|
|
|
 |
K.Hofmeyer,
and
J.E.Treisman
(2009).
The receptor protein tyrosine phosphatase LAR promotes R7 photoreceptor axon targeting by a phosphatase-independent signaling mechanism.
|
| |
Proc Natl Acad Sci U S A,
106,
19399-19404.
|
 |
|
|
|
|
 |
M.C.Balasu,
L.N.Spiridon,
S.Miron,
C.T.Craescu,
A.J.Scheidig,
A.J.Petrescu,
and
S.E.Szedlacsek
(2009).
Interface analysis of the complex between ERK2 and PTP-SL.
|
| |
PLoS ONE,
4,
e5432.
|
 |
|
|
|
|
 |
S.H.Lim,
S.K.Kwon,
M.K.Lee,
J.Moon,
D.G.Jeong,
E.Park,
S.J.Kim,
B.C.Park,
S.C.Lee,
S.E.Ryu,
D.Y.Yu,
B.H.Chung,
E.Kim,
P.K.Myung,
and
J.R.Lee
(2009).
Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.
|
| |
EMBO J,
28,
3564-3578.
|
 |
|
|
|
|
 |
A.Groen,
J.Overvoorde,
T.van der Wijk,
and
J.den Hertog
(2008).
Redox regulation of dimerization of the receptor protein-tyrosine phosphatases RPTPalpha, LAR, RPTPmu and CD45.
|
| |
FEBS J,
275,
2597-2604.
|
 |
|
|
|
|
 |
J.den Hertog,
A.Ostman,
and
F.D.Böhmer
(2008).
Protein tyrosine phosphatases: regulatory mechanisms.
|
| |
FEBS J,
275,
831-847.
|
 |
|
|
|
|
 |
L.Tabernero,
A.R.Aricescu,
E.Y.Jones,
and
S.E.Szedlacsek
(2008).
Protein tyrosine phosphatases: structure-function relationships.
|
| |
FEBS J,
275,
867-882.
|
 |
|
|
|
|
 |
S.C.Almo,
J.B.Bonanno,
J.M.Sauder,
S.Emtage,
T.P.Dilorenzo,
V.Malashkevich,
S.R.Wasserman,
S.Swaminathan,
S.Eswaramoorthy,
R.Agarwal,
D.Kumaran,
M.Madegowda,
S.Ragumani,
Y.Patskovsky,
J.Alvarado,
U.A.Ramagopal,
J.Faber-Barata,
M.R.Chance,
A.Sali,
A.Fiser,
Z.Y.Zhang,
D.S.Lawrence,
and
S.K.Burley
(2007).
Structural genomics of protein phosphatases.
|
| |
J Struct Funct Genomics,
8,
121-140.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Ostman,
C.Hellberg,
and
F.D.Böhmer
(2006).
Protein-tyrosine phosphatases and cancer.
|
| |
Nat Rev Cancer,
6,
307-320.
|
 |
|
|
|
|
 |
J.L.Sallee,
E.S.Wittchen,
and
K.Burridge
(2006).
Regulation of cell adhesion by protein-tyrosine phosphatases: II. Cell-cell adhesion.
|
| |
J Biol Chem,
281,
16189-16192.
|
 |
|
|
|
|
 |
K.Hofmeyer,
C.Maurel-Zaffran,
H.Sink,
and
J.E.Treisman
(2006).
Liprin-alpha has LAR-independent functions in R7 photoreceptor axon targeting.
|
| |
Proc Natl Acad Sci U S A,
103,
11595-11600.
|
 |
|
|
|
|
 |
N.Holmes
(2006).
CD45: all is not yet crystal clear.
|
| |
Immunology,
117,
145-155.
|
 |
|
|
|
|
 |
N.K.Tonks
(2006).
Protein tyrosine phosphatases: from genes, to function, to disease.
|
| |
Nat Rev Mol Cell Biol,
7,
833-846.
|
 |
|
|
|
|
 |
T.Takahashi,
K.Takahashi,
R.L.Mernaugh,
N.Tsuboi,
H.Liu,
and
T.O.Daniel
(2006).
A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.
|
| |
Blood,
108,
1234-1242.
|
 |
|
|
|
|
 |
Y.Xie,
S.M.Massa,
S.E.Ensslen-Craig,
D.L.Major,
T.Yang,
M.A.Tisi,
V.D.Derevyanny,
W.O.Runge,
B.P.Mehta,
L.A.Moore,
S.M.Brady-Kalnay,
and
F.M.Longo
(2006).
Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function.
|
| |
J Biol Chem,
281,
16482-16492.
|
 |
|
|
|
|
 |
A.Groen,
S.Lemeer,
T.van der Wijk,
J.Overvoorde,
A.J.Heck,
A.Ostman,
D.Barford,
M.Slijper,
and
J.den Hertog
(2005).
Differential oxidation of protein-tyrosine phosphatases.
|
| |
J Biol Chem,
280,
10298-10304.
|
 |
|
|
|
|
 |
A.Salmeen,
and
D.Barford
(2005).
Functions and mechanisms of redox regulation of cysteine-based phosphatases.
|
| |
Antioxid Redox Signal,
7,
560-577.
|
 |
|
|
|
|
 |
F.Villa,
M.Deak,
G.B.Bloomberg,
D.R.Alessi,
and
D.M.van Aalten
(2005).
Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
|
| |
J Biol Chem,
280,
8180-8187.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Del Vecchio,
and
N.K.Tonks
(2005).
The conserved immunoglobulin domain controls the subcellular localization of the homophilic adhesion receptor protein-tyrosine phosphatase mu.
|
| |
J Biol Chem,
280,
1603-1612.
|
 |
|
|
|
|
 |
T.Uinuk-Ool,
N.Nikolaidis,
A.Sato,
W.E.Mayer,
and
J.Klein
(2005).
Organization, alternative splicing, polymorphism, and phylogenetic position of lamprey CD45 gene.
|
| |
Immunogenetics,
57,
607-617.
|
 |
|
|
|
|
 |
A.K.Pedersen,
G.H.Peters G,
K.B.Møller,
L.F.Iversen,
and
J.S.Kastrup
(2004).
Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1527-1534.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Wiesmann,
K.J.Barr,
J.Kung,
J.Zhu,
D.A.Erlanson,
W.Shen,
B.J.Fahr,
M.Zhong,
L.Taylor,
M.Randal,
R.S.McDowell,
and
S.K.Hansen
(2004).
Allosteric inhibition of protein tyrosine phosphatase 1B.
|
| |
Nat Struct Mol Biol,
11,
730-737.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.F.McCain,
L.Wu,
P.Nickel,
M.U.Kassack,
A.Kreimeyer,
A.Gagliardi,
D.C.Collins,
and
Z.Y.Zhang
(2004).
Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases.
|
| |
J Biol Chem,
279,
14713-14725.
|
 |
|
|
|
|
 |
J.Felberg,
D.C.Lefebvre,
M.Lam,
Y.Wang,
D.H.Ng,
D.Birkenhead,
J.L.Cross,
and
P.Johnson
(2004).
Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation.
|
| |
J Biol Chem,
279,
3455-3462.
|
 |
|
|
|
|
 |
M.J.Chagnon,
N.Uetani,
and
M.L.Tremblay
(2004).
Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.
|
| |
Biochem Cell Biol,
82,
664-675.
|
 |
|
|
|
|
 |
N.Muja,
G.Lovas,
E.Romm,
D.Machleder,
M.Ranjan,
V.Gallo,
and
L.D.Hudson
(2004).
Expression of a catalytically inactive transmembrane protein tyrosine phosphatase epsilon (tm-PTP epsilon) delays optic nerve myelination.
|
| |
Glia,
48,
278-297.
|
 |
|
|
|
|
 |
V.B.Cismasiu,
S.A.Denes,
H.Reiländer,
H.Michel,
and
S.E.Szedlacsek
(2004).
The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu.
|
| |
J Biol Chem,
279,
26922-26931.
|
 |
|
|
|
|
 |
A.B.Huber,
A.L.Kolodkin,
D.D.Ginty,
and
J.F.Cloutier
(2003).
Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance.
|
| |
Annu Rev Neurosci,
26,
509-563.
|
 |
|
|
|
|
 |
C.H.Gray,
V.M.Good,
N.K.Tonks,
and
D.Barford
(2003).
The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase.
|
| |
EMBO J,
22,
3524-3535.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Toledano-Katchalski,
Z.Tiran,
T.Sines,
G.Shani,
S.Granot-Attas,
J.den Hertog,
and
A.Elson
(2003).
Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon.
|
| |
Mol Cell Biol,
23,
5460-5471.
|
 |
|
|
|
|
 |
N.Konishi,
K.Tsujikawa,
H.Yamamoto,
E.Ishida,
M.Nakamura,
K.Shimada,
K.Yane,
H.Yamashita,
and
S.Noguchi
(2003).
Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas.
|
| |
Br J Cancer,
88,
1223-1228.
|
 |
|
|
|
|
 |
N.X.Krueger,
R.S.Reddy,
K.Johnson,
J.Bateman,
N.Kaufmann,
D.Scalice,
D.Van Vactor,
and
H.Saito
(2003).
Functions of the ectodomain and cytoplasmic tyrosine phosphatase domains of receptor protein tyrosine phosphatase Dlar in vivo.
|
| |
Mol Cell Biol,
23,
6909-6921.
|
 |
|
|
|
|
 |
A.E.Todd,
C.A.Orengo,
and
J.M.Thornton
(2002).
Sequence and structural differences between enzyme and nonenzyme homologs.
|
| |
Structure,
10,
1435-1451.
|
 |
|
|
|
|
 |
C.Blanchetot,
L.G.Tertoolen,
J.Overvoorde,
and
J.den Hertog
(2002).
Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.
|
| |
J Biol Chem,
277,
47263-47269.
|
 |
|
|
|
|
 |
C.Blanchetot,
L.G.Tertoolen,
and
J.den Hertog
(2002).
Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress.
|
| |
EMBO J,
21,
493-503.
|
 |
|
|
|
|
 |
S.Gross,
C.Blanchetot,
J.Schepens,
S.Albet,
R.Lammers,
J.den Hertog,
and
W.Hendriks
(2002).
Multimerization of the protein-tyrosine phosphatase (PTP)-like insulin-dependent diabetes mellitus autoantigens IA-2 and IA-2beta with receptor PTPs (RPTPs). Inhibition of RPTPalpha enzymatic activity.
|
| |
J Biol Chem,
277,
48139-48145.
|
 |
|
|
|
|
 |
A.Changela,
C.K.Ho,
A.Martins,
S.Shuman,
and
A.Mondragón
(2001).
Structure and mechanism of the RNA triphosphatase component of mammalian mRNA capping enzyme.
|
| |
EMBO J,
20,
2575-2586.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Terszowski,
A.Jankowski,
W.J.Hendriks,
A.G.Rolink,
and
P.Kisielow
(2001).
Within the hemopoietic system, LAR phosphatase is a T cell lineage-specific adhesion receptor-like protein whose phosphatase activity appears dispensable for T cell development, repertoire selection and function.
|
| |
Eur J Immunol,
31,
832-840.
|
 |
|
|
|
|
 |
J.N.Andersen,
O.H.Mortensen,
G.H.Peters,
P.G.Drake,
L.F.Iversen,
O.H.Olsen,
P.G.Jansen,
H.S.Andersen,
N.K.Tonks,
and
N.P.Møller
(2001).
Structural and evolutionary relationships among protein tyrosine phosphatase domains.
|
| |
Mol Cell Biol,
21,
7117-7136.
|
 |
|
|
|
|
 |
L.G.Tertoolen,
C.Blanchetot,
G.Jiang,
J.Overvoorde,
T.W.Gadella,
T.Hunter,
and
J.den Hertog
(2001).
Dimerization of receptor protein-tyrosine phosphatase alpha in living cells.
|
| |
BMC Cell Biol,
2,
8.
|
 |
|
|
|
|
 |
M.V.Chengalvala,
A.R.Bapat,
W.W.Hurlburt,
B.Kostek,
D.S.Gonder,
R.A.Mastroeni,
and
D.E.Frail
(2001).
Biochemical characterization of osteo-testicular protein tyrosine phosphatase and its functional significance in rat primary osteoblasts.
|
| |
Biochemistry,
40,
814-821.
|
 |
|
|
|
|
 |
N.K.Tonks,
and
B.G.Neel
(2001).
Combinatorial control of the specificity of protein tyrosine phosphatases.
|
| |
Curr Opin Cell Biol,
13,
182-195.
|
 |
|
|
|
|
 |
B.K.Mueller,
M.M.Ledig,
and
S.Wahl
(2000).
The receptor tyrosine phosphatase CRYPalpha affects growth cone morphology.
|
| |
J Neurobiol,
44,
204-218.
|
 |
|
|
|
|
 |
C.Blanchetot,
and
J.den Hertog
(2000).
Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.
|
| |
J Biol Chem,
275,
12446-12452.
|
 |
|
|
|
|
 |
E.Feiken,
I.van Etten,
M.F.Gebbink,
W.H.Moolenaar,
and
G.C.Zondag
(2000).
Intramolecular interactions between the juxtamembrane domain and phosphatase domains of receptor protein-tyrosine phosphatase RPTPmu. Regulation of catalytic activity.
|
| |
J Biol Chem,
275,
15350-15356.
|
 |
|
|
|
|
 |
G.Jiang,
J.den Hertog,
and
T.Hunter
(2000).
Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.
|
| |
Mol Cell Biol,
20,
5917-5929.
|
 |
|
|
|
|
 |
H.Avraham,
S.Avraham,
and
Y.Taniguchi
(2000).
Receptor protein tyrosine phosphatases in hematopoietic cells.
|
| |
J Hematother Stem Cell Res,
9,
425-432.
|
 |
|
|
|
|
 |
L.Li,
and
J.E.Dixon
(2000).
Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases.
|
| |
Semin Immunol,
12,
75-84.
|
 |
|
|
|
|
 |
N.R.Glover,
and
A.S.Tracey
(2000).
The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
|
| |
Biochem Cell Biol,
78,
39-50.
|
 |
|
|
|
|
 |
K.L.Lim,
C.H.Ng,
and
C.J.Pallen
(1999).
Catalytic activation of the membrane distal domain of protein tyrosine phosphatase epsilon, but not CD45, by two point mutations.
|
| |
Biochim Biophys Acta,
1434,
275-283.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |